LIVZON MABPHARM INC has a total of 23 patent applications. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are EFFIMUNE, COMPUGEN LTD and LPATH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | Hong Kong | 2 | |
#7 | Republic of Korea | 2 | |
#8 | United States | 2 | |
#9 | Argentina | 1 | |
#10 | Japan | 1 | |
#11 | New Zealand | 1 | |
#12 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies | |
#5 | Unspecified technologies | |
#6 | Analysing materials | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Peng Yucai | 10 |
#2 | Zhu Baoguo | 9 |
#3 | Zhang Jingwei | 7 |
#4 | Tao Desheng | 7 |
#5 | Hu Zhenxiang | 7 |
#6 | Liou Ruey Shyan | 7 |
#7 | Li Qiang | 6 |
#8 | Liu Jie | 6 |
#9 | Sun Cecily Rou-Yun | 6 |
#10 | Sun Lee-Hwei King | 6 |
Publication | Filing date | Title |
---|---|---|
WO2019174637A1 | Completely humanized antibody molecule against tim-3, antigen-binding fragment and medical use thereof | |
WO2018210223A1 | Antibody molecule or antigen-binding fragment against tim-3 and pharmaceutical use thereof | |
EP2947454A1 | Method for detecting sample glycosylation and terminal modification states during protein purification process | |
HK1175486A1 | Humanized anti-tnf antibody | |
EP2682405A1 | Tumor necrosis factor- humanized antibody |